Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. Through the years, Cenova has built a reputation among its current and potential portfolio companies, industry leaders, multinational companies and its peers, as a leading fund for life science investments in China. Currently, Cenova has five funds under management invested in over 50 companies with a proven track record across three funds. Its investors include large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
25
Total Investments
22
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Finance, Financial Services +1
Funding Stage
Series A +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Cenova
Recent Investments (25)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Sep 2023 | |
| Series B | •••••• | Mar 2023 | |
| Series B | •••••• | Feb 2023 | |
| Venture Round | •••••• | Nov 2022 | |
| Series A | •••••• | Sep 2022 | |
|
|
Series B | •••••• | Aug 2022 |
|
|
Series A | •••••• | Jul 2022 |
|
|
Series A | •••••• | Jun 2022 |
|
|
Seed Round | •••••• | Apr 2022 |
|
|
Series A | •••••• | Apr 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.